Stock listing

Nykode Therapeutics Asa

Selected listing: A2PZ5J · LS · EUR · DE

Nykode Therapeutics Asa (Lang & Schwarz: A2PZ5J), Health Technology. Latest release Aug 20, 2026: Nykode Therapeutics : Receives New U.S. Patent Strengthening…

A2PZ5J:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A2PZ5J
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Nykode Therapeutics Asa

Nykode Therapeutics : Receives New U.S. Patent Strengthening Intellectual Property Protection for its fully individualized VB10.NEO cancer vaccine program

August 20, 2026

Nykode Therapeutics : Q1 2026 Financial Results Q1 2026 Webcast presentation

May 27, 2026

Nykode Therapeutics : Q1 2026 Financial Results Nykode Q1 2026 Report

May 27, 2026

Nykode Therapeutics : reports Q1 2026 Financial Results

May 27, 2026

Nykode Therapeutics - Quarterly Report Q1 2026

May 27, 2026

All Nykode Therapeutics Asa news →

Events

Replays

Nykode Therapeutics As (VACBF) Q2 2026 Earnings Call
Wed, Aug 26, 2026 · 03:00 AM ET
Watch
Nykode Therapeutics As (VACBF) Q1 2026 Earnings Call
Wed, May 27, 2026 · 09:00 AM ET
Watch
Nykode Therapeutics As (VACBF) Q4 2025 Earnings Call
Wed, Feb 25, 2026 · 07:00 AM ET
Watch

Research Nykode Therapeutics Asa

Nykode Therapeutics Asa company profile

View the public company page for Nykode Therapeutics Asa on 6ix.

Nykode Therapeutics Asa news

Read company news and market updates connected to Nykode Therapeutics Asa.

Nykode Therapeutics Asa investor events

Find investor webinars, events, and replay context for Nykode Therapeutics Asa.